BioCentury
ARTICLE | Company News

Icos deal

April 10, 1995 7:00 AM UTC

ICOS Corp. (ICOS) ICOS (Seattle) and Abbott Laboratories will collaborate to develop small molecule drugs that modulate certain cell adhesion molecules intracellularly. ICOS retains exclusive U.S. ri...